MENU
SCYX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

SCYNEXIS (SCYX) Ownership - Who owns SCYNEXIS?

Profile

Industry
Pharmaceuticals Other
Address
1 Evertrust Plaza
Phone
+1 201 884-5485
Employees
36
Web
https://www.scynexis.com

Details

Group
Domestic Stock Funds
Category
Pharmaceuticals
Capitalization
55.88M
P/E Ratio
1.06
Total Cash
74.36M
Projected Growth
N/A
Total Debt
15.08M
Revenue
140.14M
Risk (Beta)
1.69
Dividend Yield
N/A
Total Cash/Share
1.97
Total Debt/Equity
N/A
Revenue/Share
2.90 USD as % of share price

Fundamentals

SCYX
Capitalization
55.9M
P/E Ratio
1.06
Risk (Beta)
1.69
Dividend Yield
N/A
Total Cash
74.4M
Total Cash/Share
1.97
Total Debt
15.1M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
2.90%
Revenue
140M
ROE
N/A
Book Value
73M
P/B Ratio
0.77
Cash Flow
N/A
Earnings
1.4
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
40K
Current Ratio
6.26
Current Revenue Per Employee
199896.55
Dividends Per Share - Security
N/A
EBITDA
70.9M
Float
N/A
Float - Current
N/A
Gross Income Margin
-153.30
Revenue To Assets
62.01
Shares Held By Institutions
68M
Shares Outstanding - Current
37.8M
Total Liabilities
55.4M
Total Volume MTD
N/A
Value
N/A
Gain YTD
-50.224
View a ticker or compare two or three
SCYX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a company which engages in discovery, development and commercialization of novel anti infectives

Industry PharmaceuticalsOther

Profile
Fundamentals
Details
Industry
Pharmaceuticals Other
Address
1 Evertrust Plaza
Phone
+1 201 884-5485
Employees
36
Web
https://www.scynexis.com